Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Stimulants | 4 | 2020 | 254 | 1.730 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2020 | 34 | 1.400 |
Why?
|
| Locomotion | 5 | 2019 | 83 | 1.290 |
Why?
|
| Methamphetamine | 3 | 2021 | 233 | 0.920 |
Why?
|
| Telemetry | 3 | 2020 | 36 | 0.920 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2023 | 25 | 0.900 |
Why?
|
| Bile Ducts | 2 | 2020 | 53 | 0.890 |
Why?
|
| Ethanol | 2 | 2022 | 323 | 0.850 |
Why?
|
| Alcoholism | 2 | 2022 | 249 | 0.830 |
Why?
|
| Amphetamines | 1 | 2021 | 28 | 0.810 |
Why?
|
| Buprenorphine | 1 | 2023 | 135 | 0.790 |
Why?
|
| Naltrexone | 1 | 2021 | 62 | 0.790 |
Why?
|
| Conditioning, Operant | 2 | 2020 | 107 | 0.730 |
Why?
|
| Stereotyped Behavior | 1 | 2019 | 17 | 0.730 |
Why?
|
| Rats | 10 | 2023 | 3417 | 0.720 |
Why?
|
| Body Temperature Regulation | 1 | 2020 | 35 | 0.710 |
Why?
|
| Discrimination Learning | 1 | 2020 | 49 | 0.710 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 259 | 0.680 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 367 | 0.670 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2018 | 8 | 0.640 |
Why?
|
| Dopamine | 2 | 2019 | 190 | 0.630 |
Why?
|
| Cyclohexylamines | 1 | 2017 | 5 | 0.620 |
Why?
|
| Cyclohexanones | 1 | 2017 | 7 | 0.620 |
Why?
|
| Phencyclidine | 1 | 2017 | 21 | 0.620 |
Why?
|
| Glutamic Acid | 1 | 2018 | 111 | 0.600 |
Why?
|
| Serotonin | 1 | 2018 | 159 | 0.580 |
Why?
|
| Animals | 15 | 2023 | 14402 | 0.580 |
Why?
|
| Cannabinoids | 1 | 2018 | 108 | 0.560 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 445 | 0.500 |
Why?
|
| Benzodioxoles | 3 | 2019 | 56 | 0.470 |
Why?
|
| Pyrrolidines | 3 | 2019 | 88 | 0.450 |
Why?
|
| Rats, Long-Evans | 2 | 2023 | 29 | 0.440 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2020 | 1664 | 0.340 |
Why?
|
| Male | 12 | 2023 | 27335 | 0.330 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 1476 | 0.320 |
Why?
|
| Ligation | 2 | 2020 | 64 | 0.230 |
Why?
|
| Receptors, Opioid, mu | 1 | 2023 | 47 | 0.230 |
Why?
|
| Liver | 2 | 2020 | 1226 | 0.230 |
Why?
|
| Adrenergic Uptake Inhibitors | 2 | 2019 | 17 | 0.220 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2021 | 8 | 0.200 |
Why?
|
| Alcohol Deterrents | 1 | 2021 | 9 | 0.200 |
Why?
|
| Periplaneta | 1 | 2021 | 2 | 0.200 |
Why?
|
| Cockroaches | 1 | 2021 | 6 | 0.200 |
Why?
|
| Central Nervous System Depressants | 1 | 2021 | 78 | 0.200 |
Why?
|
| Mice | 4 | 2022 | 6428 | 0.190 |
Why?
|
| Self Administration | 2 | 2019 | 99 | 0.190 |
Why?
|
| Drug Interactions | 1 | 2021 | 206 | 0.190 |
Why?
|
| Hallucinogens | 1 | 2021 | 62 | 0.190 |
Why?
|
| Serotonin Agents | 1 | 2020 | 17 | 0.180 |
Why?
|
| Sex Characteristics | 2 | 2019 | 213 | 0.180 |
Why?
|
| Rodentia | 1 | 2020 | 19 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2020 | 87 | 0.180 |
Why?
|
| Random Allocation | 1 | 2020 | 308 | 0.170 |
Why?
|
| Impulsive Behavior | 1 | 2019 | 82 | 0.170 |
Why?
|
| Choice Behavior | 1 | 2019 | 94 | 0.160 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 82 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 500 | 0.160 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2018 | 7 | 0.160 |
Why?
|
| Body Temperature | 1 | 2017 | 83 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2017 | 94 | 0.150 |
Why?
|
| Quinuclidines | 1 | 2017 | 42 | 0.150 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2017 | 50 | 0.150 |
Why?
|
| Heart Rate | 1 | 2019 | 358 | 0.150 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 179 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2018 | 267 | 0.140 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 149 | 0.140 |
Why?
|
| Blood Pressure | 1 | 2019 | 586 | 0.140 |
Why?
|
| Pregnancy | 1 | 2023 | 2637 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2023 | 2923 | 0.130 |
Why?
|
| Female | 5 | 2023 | 28457 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1651 | 0.100 |
Why?
|
| Humans | 3 | 2023 | 54304 | 0.090 |
Why?
|
| Cerebellum | 1 | 2022 | 142 | 0.050 |
Why?
|
| Lethal Dose 50 | 1 | 2021 | 21 | 0.050 |
Why?
|
| Hippocampus | 1 | 2022 | 242 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2019 | 67 | 0.040 |
Why?
|
| Alkaloids | 1 | 2019 | 37 | 0.040 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2019 | 61 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2019 | 49 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 237 | 0.040 |
Why?
|
| Cocaine | 1 | 2019 | 184 | 0.040 |
Why?
|
| Cyclohexanols | 1 | 2017 | 23 | 0.040 |
Why?
|
| Cricetulus | 1 | 2017 | 102 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2017 | 106 | 0.040 |
Why?
|
| CHO Cells | 1 | 2017 | 123 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2017 | 126 | 0.040 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2017 | 127 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 736 | 0.030 |
Why?
|
| Indoles | 1 | 2017 | 289 | 0.030 |
Why?
|